Review Article
Enhanced Transport Capabilities via Nanotechnologies: Impacting Bioefficacy, Controlled Release Strategies, and Novel Chaperones
Table 1
Current and emerging nanotechnology.
| | Methods | Applications |
| Current | (i) Top down (ii) Batch manufacturing | (i) Enhanced bioavailability | (ii) Delayed delivery | (iii) Extended delivery | (iv) Pulsitile delivery |
| Emerging | | (i) Targeted delivery | (i) Bottom up | (ii) Simultaneous targeted, imaging, and delivery | (ii) Continuous manufacturing | (iii) Delivery to the brain (overcoming the Blood Brain Barrier) | (iii) PAT | (iv) Delivery through novel targeting chaperons, (example T-cells) | | (v) Artificial organs, tissue therapy, wound healing, and so forth. |
|
|